What are the causes of hypocalcemia in a 54-year-old male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Low calcium levels (hypocalcemia) in a 54-year-old male are most commonly caused by vitamin D deficiency, hypoparathyroidism, or chronic kidney disease, which can lead to increased mortality, incidence of fractures, and decreased quality of life 1. The causes of hypocalcemia can be multifactorial, including:

  • Vitamin D deficiency, which impairs calcium absorption from the intestines
  • Hypoparathyroidism, where the parathyroid glands don't produce enough parathyroid hormone to regulate calcium
  • Chronic kidney disease, which affects vitamin D activation
  • Certain medications like bisphosphonates, anticonvulsants, or proton pump inhibitors
  • Magnesium deficiency
  • Pancreatitis
  • Surgical removal of the parathyroid glands Other potential causes include malabsorption syndromes, certain cancers, or genetic disorders. According to the study by 1, secondary hyperparathyroidism (SHPT) is a failure of calcium homeostasis whereby increased PTH production in response to hypocalcemia (and/or hyperphosphatemia) is unable to correct plasma calcium because of organ failure or reduced calcium availability. Treatment of hypocalcemia should prioritize addressing the underlying cause, and may include calcium supplements (typically 1000-1500mg daily of elemental calcium) and vitamin D supplements (800-1000 IU daily of vitamin D3) 1. It is essential to note that severe hypocalcemia may require immediate intravenous calcium gluconate, and a comprehensive evaluation by a healthcare provider is necessary to determine the specific cause and appropriate treatment plan. The relationship between serum calcium levels and mineralization surface, osteoid surface, and cortical/total bone area has been studied, and a positive relationship has been found between serum calcium level and mineralization surface and osteoid surface 1. However, the study by 1 suggests that the pathogenesis of hypocalcemia in chronic kidney disease is complex and multifactorial, involving phosphate retention, skeletal resistance to the calcemic action of PTH, and altered vitamin D metabolism.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Causes of Low Calcium in Males

  • Hypoparathyroidism is a rare endocrine disorder characterized by hypocalcemia and low or undetectable levels of parathyroid hormone 2
  • Removal of, or damage to, the parathyroid glands at the time of anterior neck surgery is the most likely etiology of hypoparathyroidism 2
  • Autoimmune destruction of the parathyroid glands and other genetic causes also represent common etiologies of hypoparathyroidism 2
  • Hypocalcemia can also be caused by non-PTH mediated disorders, which require a comprehensive search for other causes for appropriate treatment 3
  • Other causes of hypocalcemia include postsurgical hypoparathyroidism, autoimmune disease, genetic causes, infiltrative diseases, mineral deposition, or abnormalities in serum levels of magnesium 4

Pathophysiology of Low Calcium

  • In hypoparathyroidism, the kidneys lose the calcium-conserving actions of parathyroid hormone and excrete a greater fraction of calcium, leading to hypocalcemia 2, 5
  • The lack of parathyroid hormone action on the kidney results in deregulation of renal mechanisms transporting calcium and phosphate reabsorption, leading to hypocalcemia and hyperphosphatemia 5
  • Hypocalcemia can cause neuromuscular disturbances ranging from epilepsy and tetany to mild paresthesia, and hyperphosphatemia can promote ectopic mineralization disease 5

Diagnosis and Management of Low Calcium

  • The diagnosis of hypocalcemia involves measuring serum calcium levels, and the management involves treating the underlying cause 3
  • Conventional treatment of hypoparathyroidism consists of oral calcium salts and active vitamin D, but it has limitations and can increase the risk of long-term complications 2, 4
  • PTH replacement therapy, such as recombinant human PTH(1-84) or palopegteriparatide, can effectively achieve normal serum levels of calcium and lower serum levels of phosphate, and reduce the pill burden 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypoparathyroidism.

The Journal of clinical endocrinology and metabolism, 2020

Research

Hypoparathyroidism and the Kidney.

Endocrinology and metabolism clinics of North America, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.